These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 17377499)

  • 21. p130/E2F4 binds to and represses the cdc2 promoter in response to p53.
    Taylor WR; Schonthal AH; Galante J; Stark GR
    J Biol Chem; 2001 Jan; 276(3):1998-2006. PubMed ID: 11032828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes.
    Lefkimmiatis K; Caratozzolo MF; Merlo P; D'Erchia AM; Navarro B; Levrero M; Sbisa' E; Tullo A
    Cancer Res; 2009 Nov; 69(22):8563-71. PubMed ID: 19861536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
    Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
    Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 and cell cycle dependent transcription of kinesin family member 23 (KIF23) is controlled via a CHR promoter element bound by DREAM and MMB complexes.
    Fischer M; Grundke I; Sohr S; Quaas M; Hoffmann S; Knörck A; Gumhold C; Rother K
    PLoS One; 2013; 8(5):e63187. PubMed ID: 23650552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
    Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
    Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements.
    Katula KS; Wright KL; Paul H; Surman DR; Nuckolls FJ; Smith JW; Ting JP; Yates J; Cogswell JP
    Cell Growth Differ; 1997 Jul; 8(7):811-20. PubMed ID: 9218875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription.
    Müller GA; Engeland K
    FEBS J; 2010 Feb; 277(4):877-93. PubMed ID: 20015071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter.
    Xie RL; Gupta S; Miele A; Shiffman D; Stein JL; Stein GS; van Wijnen AJ
    J Biol Chem; 2003 Jul; 278(29):26589-96. PubMed ID: 12732645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 can repress transcription of cell cycle genes through a p21(WAF1/CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements.
    Quaas M; Müller GA; Engeland K
    Cell Cycle; 2012 Dec; 11(24):4661-72. PubMed ID: 23187802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
    Cui R; Nguyen TT; Taube JH; Stratton SA; Feuerman MH; Barton MC
    J Biol Chem; 2005 Nov; 280(47):39152-60. PubMed ID: 16203738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of platelet-derived growth factor beta-receptor expression by DeltaNp73 in neuroblastoma.
    Wetterskog D; Moshiri A; Ozaki T; Uramoto H; Nakagawara A; Funa K
    Mol Cancer Res; 2009 Dec; 7(12):2031-9. PubMed ID: 19952113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.
    Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY
    Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription repression of a CCAAT-binding transcription factor CBF/HSP70 by p53.
    Chae HD; Yun J; Shin DY
    Exp Mol Med; 2005 Oct; 37(5):488-91. PubMed ID: 16264274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters.
    Liu N; Lucibello FC; Körner K; Wolfraim LA; Zwicker J; Müller R
    Nucleic Acids Res; 1997 Dec; 25(24):4915-20. PubMed ID: 9396796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain.
    Johnson RA; Shepard EM; Scotto KW
    J Biol Chem; 2005 Apr; 280(14):13213-9. PubMed ID: 15634666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.
    Uramoto H; Izumi H; Nagatani G; Ohmori H; Nagasue N; Ise T; Yoshida T; Yasumoto K; Kohno K
    Biochem J; 2003 Apr; 371(Pt 2):301-10. PubMed ID: 12534345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
    Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
    PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.